Australia - English - Department of Health (Therapeutic Goods Administration)

zimmer biomet pty ltd - 33175 - metallic femoral head prosthesis - freedom constrained modular head component hip joint replacement prosthesis. made from co/cr/mo alloy. type 1 taper. 15 degree circumferential flat to reduce head while providing additional dislocation resistance. the freedom constrained modular head is intended for use as a femoral component of a total hip prosthesis with the freedom constrained liner system. for primary and revision patients at high risk of dislocation due to a previous history of dislocation, bone loss, joint or soft tissue laxity, neuromuscular disease or intra-operative instability, and for whom all other options to constrained acetabular components have been considered.

Australia - English - Department of Health (Therapeutic Goods Administration)

zimmer biomet pty ltd - 35661 - acetabulum prosthesis - freedom constrained acetabular cup all poly standard face liner component hip joint replacement prosthesis. made from uhmwpe with titanium ring. pre-assembled constraining ring for head and liner assembly in situ. all poly option for cemented applications. freedom constrained acetabular cup all poly standard face liner is intended for use as a component of a total hip prosthesis in primary and revision patients at high risk of dislocation due to a previous history of dislocation, bone loss, joint or soft tissue laxity, neuromuscular disease or intra-operative instability, and for whom all other options to constrained acetabular components have been considered.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - alfalfa (unii: djo934brbd) (alfalfa - unii:djo934brbd), ascorbyl palmitate (unii: qn83us2b0n) (ascorbyl palmitate - unii:qn83us2b0n), cysteine (unii: k848jz4886) (cysteine - unii:k848jz4886), barley (unii: 5pwm7yli7r) (barley - unii:5pwm7yli7r), laminaria digitata (unii: 15e7c67ee8) (laminaria digitata - unii:15e7c67ee8), manganese gluconate (unii: 9yy2f980sv) (manganese cation (2+) - unii:h6ep7w5457), methionine (unii: ae28f7pnpl) (methionine - unii:ae28f7pnpl), nasturtium officinale (unii: yh89gmv676) (na - alfalfa 6 [hp_x] in 1 ml - for temporary relief of symptoms related to free radical toxicity including tingling in hands and feet, mood changes, frequent colds, poor digestion, poor blood sugar regulation, weight gain, fatigue, and constipation.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to free radical toxicity including tingling in hands and feet, mood changes, frequent colds, poor digestion, poor blood sugar regulation, weight gain, fatigue, and constipation.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

Australia - English - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml) - eye drops, solution - excipient ingredients: mannitol; sodium hydroxide; water for injections; hyetellose; sodium citrate dihydrate - cosopt preservative free is indicated in the treatment of elevated intraocular pressure (iop) in patients with ocular hypertension or open-angle glaucoma when concominant therapy is appropriate.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - alfalfa (unii: djo934brbd) (alfalfa - unii:djo934brbd), ascorbyl palmitate (unii: qn83us2b0n) (ascorbyl palmitate - unii:qn83us2b0n), cysteine (unii: k848jz4886) (cysteine - unii:k848jz4886), barley (unii: 5pwm7yli7r) (barley - unii:5pwm7yli7r), laminaria digitata (unii: 15e7c67ee8) (laminaria digitata - unii:15e7c67ee8), manganese gluconate (unii: 9yy2f980sv) (manganese cation (2+) - unii:h6ep7w5457), methionine (unii: ae28f7pnpl) (methionine - unii:ae28f7pnpl), nasturtium officinale (unii: yh89gmv6 - alfalfa 6 [hp_x] in 1 ml - for temporary relief of symptoms related to free radical toxicity including tingling in hands and feet, mood changes, frequent colds, poor digestion, fatigue, and constipation.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to free radical toxicity including tingling in hands and feet, mood changes, frequent colds, poor digestion, fatigue, and constipation.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - fluticasone propionate, quantity: 50 microgram/actuation - inhalation, pressurised - excipient ingredients: norflurane - for use in the prophylactic management of asthma in adults and in children ages 1 year and older.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - fluticasone propionate, quantity: 250 microgram/actuation - inhalation, pressurised - excipient ingredients: norflurane - for use in the prophylactic management of asthma in adults and children over 4 years of age.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - fluticasone propionate, quantity: 125 microgram/actuation - inhalation, pressurised - excipient ingredients: norflurane - for use in the prophylactic management of asthma in adults and children over 4 years of age.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. indications: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.